Influence of Shenqu Xiaoshi Oral Liquid on Intestinal Microbiome of Children With Functional Dyspepsia
Status:
Not yet recruiting
Trial end date:
2023-08-25
Target enrollment:
Participant gender:
Summary
It has been confirmed that treatment with Shenqu Xiaoshi Oral liquid (SXOL) effectively
improves dyspeptic symptoms and is well tolerated. It is not inferior to domperidone syrup
and leads to sustained improvement in Chinese children with functional dyspepsia (FD). This
study aims to evaluate the possible regulatory effect of SXOL on intestinal microbiome in
children with FD, further exploring its related mechanism.